Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Swiecie – page 53

925 clinical trials in Swiecie, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Swiecie at a glance
925
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

925 trials in Swiecie

Open in trial search

Multiple sclerosis

Not recruiting

Study on the Effectiveness and Safety of Frexalimab and Teriflunomide for Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study on Persistent Pulmonary Hypertension in Newborns Treated with Salbutamol and Sodium Chloride

Registered drug
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Salbutamol Sulfate
  • Sponsor:Medical University Of Warsaw

Prostate cancer

Not recruiting

Study on the Safety and Feasibility of PSMA-T4 for Prostate Cancer Patients

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:PSMA-T4
  • Sponsor:Narodowe Centrum Badan Jadrowych

Glioblastoma

Not recruiting

Study on the Effectiveness of Optune with Temozolomide and Pembrolizumab in Patients with Newly Diagnosed Glioblastoma

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Novocure GmbH

Ocular myasthenia

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Crohn's disease

Not recruiting

Study of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Balinatunfib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Amgen Inc.

HIV infection

Not recruiting

Study of Weekly Oral GS-1720 and GS-4182 for Untreated HIV-1 Patients

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bictegravir
  • Sponsor:Gilead Sciences Inc.

Study on the Effectiveness and Safety of Datopotamab Deruxtecan Compared to Chemotherapy in Adults with Advanced Triple-negative Breast Cancer

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:AstraZeneca AB

Study on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

Stress cardiomyopathy

Not recruiting

Study of Levosimendan and Glucose Monohydrate for Patients with Low Ejection Fraction Takotsubo Syndrome

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Medical University Of Gdansk

Migraine

Not recruiting

Study on Atogepant for Preventing Menstrual Migraine in Women

Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Swiecie

What the registry says about research in the country

01 Nephrology & Cardiovascular

Innovative research focusing on chronic kidney disease combined with hypertension, evaluating a dual therapy approach using baxdrostat and dapagliflozin to improve patient outcomes.

  • Kidney Function Preservation
  • Blood Pressure Management
  • Cardiovascular Risk Reduction

Studies aim to assess treatment effectiveness in preventing kidney failure and cardiovascular complications.

02 Psychiatric Care

Groundbreaking research evaluating the long-term safety profile of iclepertin for individuals with schizophrenia, focusing on cognitive improvement outcomes.

  • Cognitive Function
  • Treatment Safety
  • Extended Care Protocols

Extended monitoring of treatment effects in patients who completed previous clinical trials.

03 Mood Disorders

Novel investigation into the potential benefits of low-dose aspirin as a complementary treatment for bipolar disorder, exploring new therapeutic approaches.

  • Treatment Enhancement
  • Symptom Management
  • Safety Assessment

Research focuses on evaluating the efficacy of combining conventional therapy with anti-inflammatory approaches.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.